The antifungal has a backbone structure similar to some other antifungal drugs but has two sugar molecules tacked onto its tail. Those sugars are important for how the molecule kills fungi ...

C. auris is often resistant to disinfectants and antifungal drugs, and can be difficult to kill. Between 30% and 60% of the people it infects will die. Around 3.8 million people die each year of ...

Only four new antifungal drugs were approved over the last decade. The WHO urges for safer treatments and improved diagnostics, especially in low and middle-income countries, to address this ...

Investing.com -- Shares of Structure Therapeutics Inc ADR (NASDAQ: GPCR) climbed 6.8% following the news that Pfizer Inc. (NYSE: NYSE:PFE) has discontinued the development of its obesity drug ...

auris, as it not only is highly resistant to multiple antifungal drugs but also can withstand common hospital disinfectants. “CDC has deemed C. auris as an urgent AR [antimicrobial resistance ...

According to a study by the Manchester Fungal Infection Group, in 2022, approximately 6.5 million people were infected by a pathogenic fungus, and about 3.8 million died as a result – nearly twice as ...

(NEXSTAR) – New cases of a dangerous, drug-resistant fungus have been identified in at least two states’ hospital systems. Candida auris, also called C. auris, was first identified in the U.S ...

auris as a fungal pathogen of critical priority. Similarly, the Centers for Disease Control and Prevention warn that "C. auris is an emerging fungus that can cause severe, often multidrug ...

(NEXSTAR) – New cases of a dangerous, drug-resistant fungus have been identified in at least two states’ hospital systems. Candida auris, also called C. auris, was first identified in the U.S ...